PerC B-Cells Activation via Thermogenetics-Based CXCL12 Generator for Intraperitoneal Immunity against Metastatic Disseminated Tumor Cells

A dendritic cell-independent, next-generation intraperitoneal immunotherapy was described that activated peritoneal cavity B cell subsets for intraperitoneal anti-tumor immunity via exogenous antigen presentation.